Revvity
Revvity, Inc. is an American company in the life sciences and diagnostics business that is focused on selling to the pharmaceutical and biotechnology industries, especially in relation to approaches making use of new cell therapy or gene therapy developments. Its origins lie with the long-existing company PerkinElmer, which has been in a variety of business lines.
If you'd bought from year…
Same habit, different start year. Each row shows what a constant habit's worth of RVTY would be worth today, had you started buying at that point in the asset's history.
| Started | $6/day$6/day coffee | $42/wk$42/week coffee |
|---|---|---|
| Year 1 (1973) — listing | $2,612,661 32.4× | $3,779,768 32.4× |
| Year 6 (1978) | $1,100,625 15.0× | $1,595,238 15.0× |
| Year 11 (1983) | $593,323 9.0× | $859,068 9.0× |
| Year 16 (1988) | $430,035 7.4× | $622,639 7.4× |
| Year 21 (1993) | $292,692 5.8× | $424,079 5.8× |
| Year 26 (1998) | $174,176 4.1× | $252,955 4.1× |
| Year 31 (2003) | $115,129 3.3× | $167,258 3.3× |
| Year 36 (2008) | $67,070 2.4× | $97,402 2.4× |
| Year 41 (2013) | $29,004 1.4× | $42,098 1.4× |
| Year 46 (2018) | $12,123 1.0× | $17,672 1.0× |
Repeated investment, no fees, dividends reinvested. $6/day coffee = $180 / month equivalent.
Headquarters
Waltham, Massachusetts, United States
Popular scenarios with RVTY
For illustration only — not investment advice. Past performance is not indicative of future results.